These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
623 related items for PubMed ID: 6831420
1. LNCaP model of human prostatic carcinoma. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. Cancer Res; 1983 Apr; 43(4):1809-18. PubMed ID: 6831420 [Abstract] [Full Text] [Related]
2. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. Reid LM, Leav I, Kwan PW, Russell P, Merk FB. Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211 [Abstract] [Full Text] [Related]
3. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Sato N, Gleave ME, Bruchovsky N, Rennie PS, Beraldi E, Sullivan LD. Cancer Res; 1997 Apr 15; 57(8):1584-9. PubMed ID: 9108464 [Abstract] [Full Text] [Related]
4. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors. Pollack A, Irvin GL, Block NL, Lipton RM, Stover BJ, Claflin AJ. Cancer Res; 1982 Jun 15; 42(6):2184-90. PubMed ID: 7074599 [Abstract] [Full Text] [Related]
5. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ. Clin Cancer Res; 1996 Sep 15; 2(9):1627-36. PubMed ID: 9816342 [Abstract] [Full Text] [Related]
6. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. Cancer Res; 1995 Oct 01; 55(19):4438-45. PubMed ID: 7671257 [Abstract] [Full Text] [Related]
7. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ. Cancer Res; 2004 Aug 01; 64(15):5489-95. PubMed ID: 15289359 [Abstract] [Full Text] [Related]
8. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T, Lin FF, Rao P, Lin MF. Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404 [Abstract] [Full Text] [Related]
9. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Wu GJ, Peng Q, Fu P, Wang SW, Chiang CF, Dillehay DL, Wu MW. Gene; 2004 Mar 03; 327(2):201-13. PubMed ID: 14980717 [Abstract] [Full Text] [Related]
10. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP. Clin Cancer Res; 1999 Apr 03; 5(4):783-9. PubMed ID: 10213213 [Abstract] [Full Text] [Related]
11. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Invest Urol; 1979 Jul 03; 17(1):16-23. PubMed ID: 447482 [Abstract] [Full Text] [Related]
12. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel. Jackson JK, Gleave ME, Yago V, Beraldi E, Hunter WL, Burt HM. Cancer Res; 2000 Aug 01; 60(15):4146-51. PubMed ID: 10945622 [Abstract] [Full Text] [Related]
13. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM, Ouafik L. Cancer Res; 2001 Feb 01; 61(3):1196-206. PubMed ID: 11221851 [Abstract] [Full Text] [Related]
14. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells. Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM, Ouafik L. Oncogene; 2008 Jan 17; 27(4):506-18. PubMed ID: 17637748 [Abstract] [Full Text] [Related]
15. Chromosomal analysis of human prostatic adenocarcinoma cell lines. Ohnuki Y, Marnell MM, Babcock MS, Lechner JF, Kaighn ME. Cancer Res; 1980 Mar 17; 40(3):524-34. PubMed ID: 7471073 [Abstract] [Full Text] [Related]
16. Morphological, biological, and biochemical characteristics of a benign human trichilemmoma cell line in vivo and in vitro. Kanzaki T, Eto H, Umezawa A, Maeda T, Iwase H, Ito M. Cancer Res; 1981 Jun 17; 41(6):2468-75. PubMed ID: 6165463 [Abstract] [Full Text] [Related]
17. Inhibition of caspases by cytokine response modifier A blocks androgen ablation-mediated prostate cancer cell death in vivo. Srikanth S, Kraft AS. Cancer Res; 1998 Feb 15; 58(4):834-9. PubMed ID: 9485043 [Abstract] [Full Text] [Related]
18. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP. Uchida K, Masumori N, Takahashi A, Itoh N, Kato K, Matusik RJ, Tsukamoto T. Prostate; 2006 Apr 01; 66(5):536-45. PubMed ID: 16372327 [Abstract] [Full Text] [Related]
19. Hormone dependency of a serially transplantable human prostatic cancer (HONDA) in nude mice. Ito YZ, Mashimo S, Nakazato Y, Takikawa H. Cancer Res; 1985 Oct 01; 45(10):5058-63. PubMed ID: 4027985 [Abstract] [Full Text] [Related]
20. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B. Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538 [Abstract] [Full Text] [Related] Page: [Next] [New Search]